Annual report
9818.TEDINET S100W7G0
Period2024-04-01 → 2025-03-31
Filed2025-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥33.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥29.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥30.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥26.5bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥889m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥734m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥661m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥755m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥671m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥889m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥734m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥22.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥21.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥21.8bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.2bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥19.4bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.2bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥14.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.2bn | at 2023-03-31v | Cons. | Net assets |
| Net assets / equity | ¥13.4bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.7bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2023-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.3bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥858m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥981m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥291m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥531m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥445m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥116.15 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥96.09 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.78 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥99.14 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.06 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,947.66 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,849.89 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,811.07 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,754.24 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,663.56 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 67.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.8% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.1% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 668 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 642 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 614 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 545 | at 2022-03-31v | Cons. | Number of employees |
| Employees | 510 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥26.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥23.3bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥24.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥21.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥947m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥841m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥930m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥958m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥948m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥693m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥625m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥723m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥750m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥681m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥19.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥19.8bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥18.9bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.2bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.1bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.5bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥14.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥14.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥13.8bn | at 2023-03-31v | Standalone | Net assets |
| Net assets / equity | ¥13.3bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥12.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.5bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥90.57 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.89 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.94 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.37 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.41 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥27 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20.5 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,935.92 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,863.91 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,809.66 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,745.23 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.1 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 74.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.3% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,046,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,046,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 469 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 443 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 420 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 407 | at 2022-03-31v | Standalone | Number of employees |
| Employees | 388 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥6.9bn |
| Aquareportable segment | capex | 2024-04-01 → 2025-03-31 | ¥52m |
| Aquareportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥45m |
| Aquareportable segment | employees | at 2025-03-31 | 98 pure |
| Aquareportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Aquareportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Aquareportable segment | segment assets | at 2025-03-31 | ¥2.7bn |
| Aquareportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥62m |
| Livingreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥584m |
| Livingreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥512m |
| Livingreportable segment | employees | at 2025-03-31 | 331 pure |
| Livingreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥24.0bn |
| Livingreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥24.0bn |
| Livingreportable segment | segment assets | at 2025-03-31 | ¥7.4bn |
| Livingreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥737m |
| Medical And Industrial Gasreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Medical And Industrial Gasreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥643m |
| Medical And Industrial Gasreportable segment | employees | at 2025-03-31 | 239 pure |
| Medical And Industrial Gasreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥8.1bn |
| Medical And Industrial Gasreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥8.1bn |
| Medical And Industrial Gasreportable segment | segment assets | at 2025-03-31 | ¥5.1bn |
| Medical And Industrial Gasreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥467m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥33.4bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥33.4bn |
| —segment total | segment assets | at 2025-03-31 | ¥15.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥7.4bn |
| Aquareportable segment | capex | 2023-04-01 → 2024-03-31 | ¥46m |
| Aquareportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥46m |
| Aquareportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Aquareportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Aquareportable segment | segment assets | at 2024-03-31 | ¥2.6bn |
| Aquareportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥60m |
| Livingreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥577m |
| Livingreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥493m |
| Livingreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥21.4bn |
| Livingreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥21.4bn |
| Livingreportable segment | segment assets | at 2024-03-31 | ¥7.1bn |
| Livingreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥645m |
| Medical And Industrial Gasreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥937m |
| Medical And Industrial Gasreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥492m |
| Medical And Industrial Gasreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥7.3bn |
| Medical And Industrial Gasreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥7.3bn |
| Medical And Industrial Gasreportable segment | segment assets | at 2024-03-31 | ¥4.8bn |
| Medical And Industrial Gasreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥350m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.0bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥29.9bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥29.9bn |
| —segment total | segment assets | at 2024-03-31 | ¥14.4bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Aquareportable segment | employees | at 2025-03-31 | 98 pure |
| Livingreportable segment | employees | at 2025-03-31 | 236 pure |
| Medical And Industrial Gasreportable segment | employees | at 2025-03-31 | 135 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,690
| Item | Context | Value | Unit |
|---|---|---|---|
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000FurunoAkiraMember | 1953-04-01 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000FurunoAkiraMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000FurunoAkiraMember | Original text (Japanese)(注)２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000IuchiKiyokazuMember | Original text (Japanese)代表取締役社長執行役員 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000IuchiKiyokazuMember | Original text (Japanese)居 内 清 和 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000IuchiKiyokazuMember | 1971-05-12 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000IuchiKiyokazuMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000IuchiKiyokazuMember | Original text (Japanese)(注)２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000AokiAtsuhitoMember | Original text (Japanese)取締役専務執行役員医療・産業ガス事業本部長兼医療ガス部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000AokiAtsuhitoMember | Original text (Japanese)青 木 重 人 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000AokiAtsuhitoMember | 1962-08-16 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000AokiAtsuhitoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000AokiAtsuhitoMember | Original text (Japanese)(注)２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MiyamaeMasahikoMember | Original text (Japanese)取締役常務執行役員総務部長兼情報企画部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MiyamaeMasahikoMember | Original text (Japanese)宮 前 雅 彦 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MiyamaeMasahikoMember | 1965-02-02 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000MiyamaeMasahikoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MiyamaeMasahikoMember | Original text (Japanese)(注)２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000TsukamotoTeruhisaMember | Original text (Japanese)取締役上席執行役員財務部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000TsukamotoTeruhisaMember | Original text (Japanese)塚 本 晃 久 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000TsukamotoTeruhisaMember | 1967-06-14 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000TsukamotoTeruhisaMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000TsukamotoTeruhisaMember | Original text (Japanese)(注)２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000NobuhiroEchuMember | Original text (Japanese)取締役上席執行役員在宅医療部長 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000NobuhiroEchuMember | Original text (Japanese)越 中 紳 浩 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000NobuhiroEchuMember | 1966-10-02 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000NobuhiroEchuMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000NobuhiroEchuMember | Original text (Japanese)(注)２ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000OgawaMitsuguMember | Original text (Japanese)取締役(監査等委員) | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000OgawaMitsuguMember | Original text (Japanese)小 川 貢 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000OgawaMitsuguMember | 1962-03-29 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000OgawaMitsuguMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000OgawaMitsuguMember | Original text (Japanese)(注)３ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsuiDaisukeMember | Original text (Japanese)取締役(監査等委員) | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsuiDaisukeMember | Original text (Japanese)松 井 大 輔 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsuiDaisukeMember | 1968-12-17 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000MatsuiDaisukeMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsuiDaisukeMember | Original text (Japanese)(注)３ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsumotoHiromiMember | Original text (Japanese)取締役(監査等委員) | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsumotoHiromiMember | Original text (Japanese)松本 裕美（戸籍名：岸田裕美） | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsumotoHiromiMember | 1959-09-04 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E02739-000MatsumotoHiromiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02739-000MatsumotoHiromiMember | Original text (Japanese)(注)３ | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |